ArticleCancers2020

Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk Patients.

Tomohiro Horio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.